Paper17252012
Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase.
Diaz-Blanco E and 16 others. Leukemia, 2007. Cited by 125 papers, by iCite.
Cite this record
ConductScience Library. Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase. Papers, record 17252012. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17252012
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase.
- PubMed
Topics24
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gene Expression Profiling | Major topic |
| Gene Expression Regulation, Leukemic | Major topic |
| Hematopoietic Stem Cells | Major topic |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Major topic |
| Leukemia, Myeloid, Chronic-Phase | Major topic |
| Neoplasm Proteins | Major topic |
| Neoplastic Stem Cells | Major topic |
| Antigens, CD34 | |
| Apoptosis | |
| Cell Adhesion | |
| Cell Differentiation | |
| Cell Division | |
| DNA, Complementary | |
| DNA, Neoplasm | |
| Fusion Proteins, bcr-abl | |
| Humans | |
| Intercellular Signaling Peptides and Proteins | |
| RNA, Messenger | |
| RNA, Neoplasm | |
| Receptors, Cell Surface | |
| Receptors, Growth Factor | |
| Receptors, Leptin | |
| Signal Transduction | |
| Up-Regulation |
Source PubMed
References75
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8861914 | Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. | Cell | 1996 | https://conductscience.org/library/papers/8861914 | PubMed |
| 2 | 10403855 | The biology of chronic myeloid leukemia. | N Engl J Med | 1999 | https://conductscience.org/library/papers/10403855 | PubMed |
| 3 | 16728981 | Gene expression signature of primary imatinib-resistant chronic myeloid leukemia patients. | Leukemia | 2006 | https://conductscience.org/library/papers/16728981 | PubMed |
| 4 | 9788612 | Pharmacological inhibitors of mammalian fatty acid synthase suppress DNA replication and induce apoptosis in tumor cell lines. | Cancer Res | 1998 | https://conductscience.org/library/papers/9788612 | PubMed |
| 5 | 3474529 | Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia. | Nature | 1987 | https://conductscience.org/library/papers/3474529 | PubMed |
| 6 | 12639219 | Tissue inhibitor of metalloproteinases-1 signalling pathway leading to erythroid cell survival. | Biochem J | 2003 | https://conductscience.org/library/papers/12639219 | PubMed |
| 7 | 9949177 | GCKR links the Bcr-Abl oncogene and Ras to the stress-activated protein kinase pathway. | Blood | 1999 | https://conductscience.org/library/papers/9949177 | PubMed |
| 8 | 1525828 | Dominant negative MYC blocks transformation by ABL oncogenes. | Cell | 1992 | https://conductscience.org/library/papers/1525828 | PubMed |
| 9 | 9207453 | Characterization of cell cycle status and E2F complexes in mobilized CD34+ cells before and after cytokine stimulation. | Blood | 1997 | https://conductscience.org/library/papers/9207453 | PubMed |
| 10 | 9670022 | Activation of RhoA and SAPK/JNK signalling pathways by the RhoA-specific exchange factor mNET1. | EMBO J | 1998 | https://conductscience.org/library/papers/9670022 | PubMed |
| 11 | 16293596 | A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation. | Blood | 2006 | https://conductscience.org/library/papers/16293596 | PubMed |
| 12 | 8962092 | Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells. | Proc Natl Acad Sci U S A | 1996 | https://conductscience.org/library/papers/8962092 | PubMed |
| 13 | 11012149 | Differences between normal and CML stem cells: potential targets for clinical exploitation. | Stem Cells | 1998 | https://conductscience.org/library/papers/11012149 | PubMed |
| 14 | 16144796 | Molecular profiling of CD34+ cells identifies low expression of CD7, along with high expression of proteinase 3 or elastase, as predictors of longer survival in patients with CML. | Blood | 2006 | https://conductscience.org/library/papers/16144796 | PubMed |
| 15 | 8246975 | A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins. | Mol Cell Biol | 1993 | https://conductscience.org/library/papers/8246975 | PubMed |
| 16 | 8755665 | Bcr/Abl expression stimulates integrin function in hematopoietic cell lines. | J Clin Invest | 1996 | https://conductscience.org/library/papers/8755665 | PubMed |
| 17 | 12813469 | Chronic myelogenous leukemia molecular signature. | Oncogene | 2003 | https://conductscience.org/library/papers/12813469 | PubMed |
| 18 | 12576334 | Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment. | Blood | 2003 | https://conductscience.org/library/papers/12576334 | PubMed |
| 19 | 10989189 | Transforming growth factor inhibits erythropoiesis by blocking proliferation and accelerating differentiation of erythroid progenitors. | Exp Hematol | 2000 | https://conductscience.org/library/papers/10989189 | PubMed |
| 20 | 10779447 | Selectively increased growth of fetal hemoglobin-expressing adult erythroid progenitors after brief treatment of early progenitors with transforming growth factor beta. | Blood | 2000 | https://conductscience.org/library/papers/10779447 | PubMed |
Cited by86
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 125 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41850237 | FBXO3-mediated DUSP9 ubiquitination promotes leukemia stem cell maintenance and tyrosine kinase inhibitor resistance in chronic myeloid leukemia. | Cell Rep Med | 2026 | https://conductscience.org/library/papers/41850237 | PubMed |
| 41735647 | Potential utility of PPARγ agonists in targeting chronic myeloid leukemia stem cells. | Ann Hematol | 2026 | https://conductscience.org/library/papers/41735647 | PubMed |
| 41008876 | Lipid Storage and Therapy Resistance in Chronic Myeloid Leukaemia: A Novel Perspective on Targeting Metabolic Vulnerabilities. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41008876 | PubMed |
| 40671124 | Martinostat as a novel HDAC inhibitor to overcome tyrosine kinase inhibitor resistance in chronic myeloid leukemia. | Clin Epigenetics | 2025 | https://conductscience.org/library/papers/40671124 | PubMed |
| 39939817 | Uncovering two neutrophil-committed progenitors that immediately precede promyelocytes during human neutropoiesis. | Cell Mol Immunol | 2025 | https://conductscience.org/library/papers/39939817 | PubMed |
| 39384770 | The multiple roles of interferon regulatory factor family in health and disease. | Signal Transduct Target Ther | 2024 | https://conductscience.org/library/papers/39384770 | PubMed |
| 38704604 | Antileukemic potential of methylated indolequinone MAC681 through immunogenic necroptosis and PARP1 degradation. | Biomark Res | 2024 | https://conductscience.org/library/papers/38704604 | PubMed |
| 37578596 | Characterization of K562 cells: uncovering novel chromosomes, assessing transferrin receptor expression, and probing pharmacological therapies. | Cell Mol Life Sci | 2023 | https://conductscience.org/library/papers/37578596 | PubMed |
| 37476380 | Profiling of miRNAs and their interfering targets in peripheral blood mononuclear cells from patients with chronic myeloid leukaemia. | Front Oncol | 2023 | https://conductscience.org/library/papers/37476380 | PubMed |
| 37115622 | Predictive nonlinear modeling of malignant myelopoiesis and tyrosine kinase inhibitor therapy. | Elife | 2023 | https://conductscience.org/library/papers/37115622 | PubMed |
| 36660357 | Downregulation of Stearoyl-CoA Desaturase 1 (SCD-1) Promotes Resistance to Imatinib in Chronic Myeloid Leukemia. | Mediterr J Hematol Infect Dis | 2023 | https://conductscience.org/library/papers/36660357 | PubMed |
| 36536477 | Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism. | Clin Transl Med | 2022 | https://conductscience.org/library/papers/36536477 | PubMed |
| 36289338 | Subtype-specific 3D genome alteration in acute myeloid leukaemia. | Nature | 2022 | https://conductscience.org/library/papers/36289338 | PubMed |
| 35764681 | Impact on outcomes of mixed chimerism of bone marrow CD34+ sorted cells after matched or haploidentical allogeneic stem cell transplantation for myeloid malignancies. | Bone Marrow Transplant | 2022 | https://conductscience.org/library/papers/35764681 | PubMed |
| 35628271 | The Head-to-Toe Hormone: Leptin as an Extensive Modulator of Physiologic Systems. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35628271 | PubMed |
| 34944883 | Comparison of the Transcriptomic Signatures in Pediatric and Adult CML. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34944883 | PubMed |
| 34771705 | Statins Enhance the Molecular Response in Chronic Myeloid Leukemia when Combined with Tyrosine Kinase Inhibitors. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34771705 | PubMed |
| 34508131 | Compromised anti-tumor-immune features of myeloid cell components in chronic myeloid leukemia patients. | Sci Rep | 2021 | https://conductscience.org/library/papers/34508131 | PubMed |
| 34139044 | Nilotinib-induced bone marrow CD34+/lin-Ph+ cells early clearance in newly diagnosed CP-Chronic Myeloid Leukemia: Final report of the PhilosoPhi34 study. | Eur J Haematol | 2021 | https://conductscience.org/library/papers/34139044 | PubMed |
| 33742137 | Reducing FASN expression sensitizes acute myeloid leukemia cells to differentiation therapy. | Cell Death Differ | 2021 | https://conductscience.org/library/papers/33742137 | PubMed |
Genes10
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABL1 | 25 | PubTator's text mining | https://conductscience.org/library/genes/25 | NCBI Gene |
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| CD34 | 947 | PubTator's text mining | https://conductscience.org/library/genes/947 | NCBI Gene |
| HOXA9 | 3205 | PubTator's text mining | https://conductscience.org/library/genes/3205 | NCBI Gene |
| IRF8 | 3394 | PubTator's text mining | https://conductscience.org/library/genes/3394 | NCBI Gene |
| LEPR | 3953 | PubTator's text mining | https://conductscience.org/library/genes/3953 | NCBI Gene |
| MEIS1 | 4211 | PubTator's text mining | https://conductscience.org/library/genes/4211 | NCBI Gene |
| SELENOP | 6414 | PubTator's text mining | https://conductscience.org/library/genes/6414 | NCBI Gene |
| SRI | 6717 | PubTator's text mining | https://conductscience.org/library/genes/6717 | NCBI Gene |
| TGFB1 | 7040 | PubTator's text mining | https://conductscience.org/library/genes/7040 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17252012
GET https://conductscience.org/api/papers/v1/17252012/references?page=2